FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386484550> ?p ?o ?g. }

• W4386484550 endingPage "4440" @default.
• W4386484550 startingPage "4440" @default.
• W4386484550 abstract "The presence of a serum paraprotein (PP) is usually associated with plasma-cell dyscrasias, Waldenstrom Macroglobulinemia/lymphoplasmacytic lymphoma, and cryoglobulinemia. However, PP is also often reported in other high- and low-grade B-cell malignancies. As these reports are sparse and heterogeneous, an overall view on this topic is lacking, Therefore, we carried out a complete literature review to detail the characteristics, and highlight differences and similarities among lymphoma entities associated with PP. In these settings, IgM and IgG are the prevalent PP subtypes, and their serum concentration is often low or even undetectable without immunofixation. The relevance of paraproteinemia and its prevalence, as well as the impact of IgG vs. IgM PP, seems to differ within B-NHL subtypes and CLL. Nonetheless, paraproteinemia is almost always associated with advanced disease, as well as with immunophenotypic, genetic, and clinical features, impacting prognosis. In fact, PP is reported as an independent prognostic marker of poor outcome. All the above call for implementing clinical practice, with the assessment of paraproteinemia, in patients' work-up. Indeed, more studies are needed to shed light on the biological mechanism causing more aggressive disease. Furthermore, the significance of paraproteinemia, in the era of targeted therapies, should be assessed in prospective trials." @default.
• W4386484550 created "2023-09-07" @default.
• W4386484550 creator A5003545568 @default.
• W4386484550 creator A5016028588 @default.
• W4386484550 creator A5025046387 @default.
• W4386484550 creator A5054317101 @default.
• W4386484550 creator A5070384560 @default.
• W4386484550 date "2023-09-06" @default.
• W4386484550 modified "2023-10-17" @default.
• W4386484550 title "Serum Paraprotein Is Associated with Adverse Prognostic Factors and Outcome, across Different Subtypes of Mature B-Cell Malignancies—A Systematic Review" @default.
• W4386484550 cites W1006481187 @default.
• W4386484550 cites W1552146172 @default.
• W4386484550 cites W1967676932 @default.
• W4386484550 cites W1968391002 @default.
• W4386484550 cites W1978235645 @default.
• W4386484550 cites W1979580373 @default.
• W4386484550 cites W2023066582 @default.
• W4386484550 cites W2033972165 @default.
• W4386484550 cites W2036435994 @default.
• W4386484550 cites W2038138703 @default.
• W4386484550 cites W2038896603 @default.
• W4386484550 cites W2068953587 @default.
• W4386484550 cites W2091704080 @default.
• W4386484550 cites W2115640419 @default.
• W4386484550 cites W2116349263 @default.
• W4386484550 cites W2125085675 @default.
• W4386484550 cites W2130852858 @default.
• W4386484550 cites W2136272158 @default.
• W4386484550 cites W2139250592 @default.
• W4386484550 cites W2139857311 @default.
• W4386484550 cites W2142438265 @default.
• W4386484550 cites W2144451670 @default.
• W4386484550 cites W2159182675 @default.
• W4386484550 cites W2160378262 @default.
• W4386484550 cites W2264971900 @default.
• W4386484550 cites W2305905180 @default.
• W4386484550 cites W2491616953 @default.
• W4386484550 cites W2612999767 @default.
• W4386484550 cites W2671474439 @default.
• W4386484550 cites W2738034667 @default.
• W4386484550 cites W2762450632 @default.
• W4386484550 cites W2788803761 @default.
• W4386484550 cites W2797584152 @default.
• W4386484550 cites W2800320119 @default.
• W4386484550 cites W2801763724 @default.
• W4386484550 cites W2883666161 @default.
• W4386484550 cites W2884732785 @default.
• W4386484550 cites W2888045036 @default.
• W4386484550 cites W2915810747 @default.
• W4386484550 cites W2945525000 @default.
• W4386484550 cites W2950023551 @default.
• W4386484550 cites W2954311907 @default.
• W4386484550 cites W2960048566 @default.
• W4386484550 cites W2982693889 @default.
• W4386484550 cites W2997857945 @default.
• W4386484550 cites W3018609885 @default.
• W4386484550 cites W3020657373 @default.
• W4386484550 cites W3037670639 @default.
• W4386484550 cites W3044366412 @default.
• W4386484550 cites W3082279985 @default.
• W4386484550 cites W3096888398 @default.
• W4386484550 cites W3106315654 @default.
• W4386484550 cites W4200304932 @default.
• W4386484550 cites W4281485894 @default.
• W4386484550 cites W4283381496 @default.
• W4386484550 cites W4296773811 @default.
• W4386484550 cites W4310356807 @default.
• W4386484550 cites W4375863990 @default.
• W4386484550 cites W4380681326 @default.
• W4386484550 cites W4385751723 @default.
• W4386484550 doi "https://doi.org/10.3390/cancers15184440" @default.
• W4386484550 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37760410" @default.
• W4386484550 hasPublicationYear "2023" @default.
• W4386484550 type Work @default.
• W4386484550 citedByCount "0" @default.
• W4386484550 crossrefType "journal-article" @default.
• W4386484550 hasAuthorship W4386484550A5003545568 @default.
• W4386484550 hasAuthorship W4386484550A5016028588 @default.
• W4386484550 hasAuthorship W4386484550A5025046387 @default.
• W4386484550 hasAuthorship W4386484550A5054317101 @default.
• W4386484550 hasAuthorship W4386484550A5070384560 @default.
• W4386484550 hasBestOaLocation W43864845501 @default.
• W4386484550 hasConcept C126322002 @default.
• W4386484550 hasConcept C143998085 @default.
• W4386484550 hasConcept C159654299 @default.
• W4386484550 hasConcept C163864487 @default.
• W4386484550 hasConcept C203014093 @default.
• W4386484550 hasConcept C2776148967 @default.
• W4386484550 hasConcept C2776364478 @default.
• W4386484550 hasConcept C2776391228 @default.
• W4386484550 hasConcept C2779134260 @default.
• W4386484550 hasConcept C2779338263 @default.
• W4386484550 hasConcept C2781038049 @default.
• W4386484550 hasConcept C2908711476 @default.
• W4386484550 hasConcept C2910423619 @default.
• W4386484550 hasConcept C542903549 @default.
• W4386484550 hasConcept C63363279 @default.
• W4386484550 hasConcept C71924100 @default.

• next